Earnings Reportpositive
Earnings Report
Other upcoming events for AMRX
Phase 3 ReadoutPhase 3 Topline: Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (
Phase 3 ReadoutPhase 3 Topline: Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth F
Phase 3 ReadoutPhase 3 Topline: A Randomized Phase III Trial of Carboplatin, Paclitaxel, Pembrolizumab Versus Carboplatin, Paclitaxe
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.